Virtual Medicinal Product (VMP) - Rivaroxaban 5mg/ml oral suspension sugar free
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Rivaroxaban 5mg/ml oral suspension sugar free | Start Date 21-05-2025 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Free From
- Sugar-free
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- BNF Codes
-
- BNF code 02080200
| Code | Start Date | End Date |
|---|---|---|
| 45160111000001108 | 21-05-2025 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Rivaroxaban | Based on Ingredient Substance | 5 mg | 1 ml |
Name
Rivaroxaban
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMRivaroxaban
-
VMP(Current) Rivaroxaban 5mg/ml oral suspension s...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 200 ml |